144,608,839[1] doses administered 47,947,097[1] people are fully vaccinated as of 25 Feb 2024
Outcome
90+% of the Italian population aged 12+ have received one dose 87+% of the Italian population aged 12+ is fully vaccinated 81.21% of the Italian population is fully vaccinated
Map of Italy showing total cumulative vaccination numbers per region as of 20th of January 2020.
The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union.
The vaccination campaign was managed by the Ministry of Health and the special commissioner Domenico Arcuri until 1 March 2021,[2][3] when he was replaced by Army General Francesco Paolo Figliuolo.[4]
Vaccination against COVID-19 is mandatory for all workers, older than 50, in Italy since October 15. [5]
Vaccination program
In the first months of the vaccination campaign, the governmental agencies targeted the health medical and administrative personnel, together with the guests and personnel of nursing homes.[6]
In the second phase of the campaign, elderly people and public service personnel should receive the vaccine.[6]
The vaccination campaign started on 27 December 2020, when Italy received 9,750 doses of the Pfizer–BioNTech COVID-19 vaccine. These doses were entirely used in the following days to vaccinate part of the medical and health personnel of hospitals.[citation needed]
The Italian vaccination campaign was coordinated and agreed with the European Union (EU). The EU countries, as per previous agreements, received the vaccine provisions according to a centralized plan developed by the European Commission.[12][13]
On 30 December 2020, 359,775 doses of vaccine were delivered by Pfizer–BioNTech.[12]
On 31 December 2020, 110,175 doses of vaccine were delivered by Pfizer–BioNTech.[12]
January 2021
From 30 December 2020 to 1 January 2021, 469,950 doses of vaccine were delivered by Pfizer-BioNTech.[12]
From 5 January 2021 to 7 January 2021, Pfizer-BioNTech delivered another 438 750 doses. This type of vaccine must be stored at -70°C. The first Italian region to start with vaccinations was Lazio, at the Spallanzani Hospital in Rome. Subsequently, the vaccines were distributed in the other Italian regions.[citation needed]
On 6 January 2021, the European Medicines Agency (EMA) gave its authorization for the Moderna vaccine.[14] At 8 pm on 7 January 2021, 379,910 people were vaccinated in Italy.[12]
According to a scientific study of COVID-19 virology, the Pfizer–BioNTech COVID-19 vaccine also protects against the two mutations of the virus that have spread in the United Kingdom and South Africa.[15]
Both strains share a common mutation called N501Y, a slight alteration at one point in the protein that covers the virus.[15]
On 10 January 2021, the Campania region in Italy had the highest percentage of administration compared to the doses possessed. It also claimed to have exhausted the stock.[16][17]
On 11 January 2021, 75,075 doses of vaccine were delivered by Pfizer–BioNTech.[12]
On 12 January 2021, 47,000 doses of vaccine were delivered by Moderna.[18]
On 11 and 12 January 2021, 488,475 doses were delivered.[12]
Pfizer has reduced vaccine availability by 29% as of 18 January 2021.[19][20] On 16 January 2021, 800 doses of Moderna vaccine were lost due to freezer failure in Forlì.[21]
On 18 and 19 January 2021, there are further delays and reductions in the number of Pfizer–BioNTech COVID-19 vaccines.[22][23]
On 20 January 2021, the vaccination campaign was slowed down due to a lack of vaccine stock.[24]
On 20 January 2021, AstraZeneca delays the delivery of the vaccine and reduces the expected quantities for deliveries across Europe.[25]
The delay in vaccine supply is delaying the vaccination campaign. On January 29, 2021, Moderna also cut vaccine supplies by 20%. About 300,000 doses are missing in the supply of vaccines provided for in the agreements with Moderna.[26]
The European Union is in sharp confrontation with AstraZeneca on the timing and quantity of vaccine supplies. This leads to a serious delay in the Italian and European vaccination campaign.[27]
On 2 February 2021, the vaccination campaign is slowing sharply due to a lack of deliveries of vaccines by pharmaceutical companies.[28][29]
On 6 February 2021, the first 249,600 doses of the AstraZeneca vaccine arrived in Italy.[10]
On 12 February 2021, the GenoesearchitectRenzo Piano was the first to undergo vaccination on Silver Vaccine Day that opens the vaccination campaign for the persons over 80 years old in Liguria.[30][31]
On 17 February 2021, AIFA extend the administration of the AstraZeneca vaccine until 65 years old.[32]
On 11 March 2021, AIFA banned the use in Italy of a batch (number ABV2856) of the AstraZeneca vaccine for checks in relation to the deaths of two men in Sicily after administration of the vaccine.[38][39][40]
On 15 March 2021, AIFA suspends the AstraZeneca vaccine throughout Italy on a temporary basis for investigations into death cases after vaccination.[41][42][43]
On 19 March 2021, AIFA revoked the ban for AstraZeneca, vaccinations have resumed.[44]
On 30 March 2021, Prime Minister Mario Draghi and his wife Maria Serenella Cappello were vaccinated with the AstraZeneca vaccine in the Termini station hub in Rome, as required by the Lazio Region vaccination plan.[46]
April 2021
On 3 April 2021, a firebombing occurred at a vaccine cold storage site in Brescia but did not damage the building's electrical supply, meaning vaccines remained usable.[47]
On 6 April 2021, AstraZeneca postponed delivery of 50% doses scheduled for 14 April 2021.[48]
In Italy, 54% of doses of AstraZeneca vaccine have been administered to date (2,218,038 out of 4,098,800 delivered), according to the Ministero della Salute, while for Moderna vaccine the percentage drops to 50% (658,403 out of 1,328,200). Pfizer vaccine has a 96% administration rate, (8,375,625 out of 8,709,480). In total, out of 14,136,480 doses of the three vaccines arrived in Italy, 11,252,066 were administered, about 80%. [50]
On 13 April 2021, 184,000 doses of the Janssen vaccine arrived in Italy, however Johnson & Johnson announced that it would delay deliveries of its vaccines to Europe.[51]
AIFA has cautiously suspended distribution to vaccination centers pending information from the United States where the Janssen vaccine has been suspended for investigation into suspicious deaths and thrombosis disorders following the administration of the Janssen vaccine.[51][52]
On 22 April 2021, Johnson & Johnson vaccine started to administration in Italy.[11]
May 2021
On 1 May 2021, Italy reached 20 million administered vaccine doses. At this point, the country had vaccinated 14 million with at least a single dose and 6 million are fully vaccinated.[53][54][55]
On 2 May 2021, two anti-vaxxers were arrested and charged with terrorism offences for the firebombing at the Brescia vaccination centre.[47]
On 10 May 2021, a nurse accidentally injected a patient with 6 doses of Pfizer BioNTech.[56]
On 22 May 2021, Italy reached 30 million administered vaccine doses.[57] At this point, the country has 9.9 million people vaccinated with a double dose.[12]
June 2021
On 1 June 2021, Italy reached 35 million administered vaccine doses. At this point, the country has 12 million people vaccinated with a double dose.[12]
On 10 June 2021, Italy reached 40 million administered vaccine doses.[12]
On 28 June 2021, Italy reached 50 million administered vaccine doses.[12]
July 2021
On 16 July 2021, Italy reached 60 million administered vaccine doses.[12] At this point, the country has 25 million people vaccinated with a double dose.[12]
August 2021
On 5 August 2021, Italy reached 70 million administered vaccine doses.[12][58]
September 2021
On 9 September 2021, Italy reached 80 million administered vaccine doses.[12][59][60]
October 2021
Third dose vaccinations begin to fragile subjects and health workers.[citation needed]
November 2021
On 3 November 2021, Italy reached 90 million administered vaccine doses.[citation needed]
On 9 December 2021, Italy reached 100 million administered vaccine doses.[62] The pediatric mRNA vaccine Comirnaty (Pfizer) authorized by the European Medicines Agency (EMA) and the Italian Medicines Agency (AIFA) is reserved for children aged 5–11.
On 16 December 2021, the vaccinations for children with the pediatric vaccine began.[63]
On 27 December 2021, exactly one year from the start of the vaccination campaign, Italy administered 108 million doses.[64]
The Therapeutic Goods Administration (TGA) is the medicine and therapeutic regulatory agency of the Australian Government. As part of the Department of Health and Aged Care, the TGA regulates the quality, supply and advertising of medicines, pathology devices, medical devices, blood products and most other therapeutics. Any items that claim to have a therapeutic effect, are involved in the administration of medication, or are otherwise covered by the Therapeutic Goods Act 1989, the Therapeutic Goods Regulations 1990, or a ministerial order, must be approved by the TGA and registered in the Australian Register of Therapeutic Goods.
COVID-19 vaccination in Switzerland is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.
The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, with the goal of vaccinating all willing people in Australia before 2022. Front-line workers and aged care staff and residents had priority for being inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine was not included in the Australian vaccination program as of June 2021.
COVID-19 vaccination in Canada is an ongoing, intergovernmental effort coordinated between the bodies responsible in the Government of Canada to acquire and distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic in Canada. Provinces have worked with local municipal governments, hospital systems, family doctors and independently owned pharmacies to aid in part, or in full with vaccination rollout. The vaccination effort in full is the largest such immunization effort in the nation's history. The vaccination effort began December 14, 2020, and is currently ongoing.
COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The virus causing COVID-19 was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021.
COVID-19 vaccination programs are ongoing in the majority countries and territories in Africa, with 51 of 54 African countries having launched vaccination programs by July 2021. As of October 2023, 51.8% of the continent's population is fully vaccinated with over 1084.5 million doses administered.
Bhutan has promised a free COVID-19 vaccination to all of its citizens, both inside and outside the country. It started mass vaccinations on 27 March 2021.
The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.
The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks third in Asia and fifth in the world.
The COVID-19 vaccination program in Argentina is an ongoing effort of mass immunization. Vaccination against COVID-19 began in Argentina on 29 December 2020 aiming at health professionals. Argentina struck a deal with the United Kingdom in November 2020 for a British made vaccine produced by the pharmaceutical company AstraZeneca and the University of Oxford. The vaccines are part of a deal where Argentina received 22.4 million doses. During the first week, 39,599 doses were applied to health professionals.
Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.
COVID-19 vaccination in Iceland is an effort to immunize the adult population of Iceland due to the COVID-19 pandemic. As of July 2021, more than 260,000 individuals had received at least one dose of COVID-19 vaccine, which was over 78% of the country's population. On November 21, 2021, 90% of the target population had been fully vaccinated, while around 1 in 5 people had received a booster on top of that; by December 9, 2021, the share of the population having received a booster shot exceeded 50%. On December 13, 2021, the country began offering Pfizer vaccinations to children aged 5–11.
COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.
COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both the Pfizer and Moderna vaccines increased significantly. By May 2021, over 50 percent of Ontarians had received their first dose. By the beginning of 2022, over 80 percent of Ontarians had received their first dose.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
